Most Popular

China’s Impact on Global Financial Markets

Isha Agarwal, Grace Weishi Gu, Eswar Prasad, Dec 18, 2019

China has been shifting the composition of its external assets from accumulation of foreign reserves toward private, nonofficial outflows. This article provides an overview of the allocation patterns of outward equity investment by Chinese institutional investors (IIs) across destination countries and sectors. In their foreign portfolios, Chinese IIs overweight sectors in which China has a comparative disadvantage (for instance, computer software), and they concentrate...

State Versus Market: China’s Infrastructure Investment

Shuoge Qian, Hong Ru, Wei Xiong, Mar 13, 2024

In 2005, the Chinese government launched the landmark “36 Clauses” reform, marking a critical step toward forging a more favorable market environment.

An Empirical Overview of Chinese Capital Market

Grace Xing Hu, Jun Pan, Jiang Wang, Jun 29, 2022

We provide an empirical review of the Chinese capital market, focusing on the basic return and risk characteristics of its major asset classes, as well as a comparison to the US market. All major asset classes in China have significant higher volatilities than their counterparts in the US market, but they do not always yield larger returns. Small-company stocks, short-, medium-, and long-term treasury bonds outperform their US counterparts, while large stocks underperform and long-term enterprise bonds yield similar returns.

Dollar Appreciation and Asian Economies

Zheng Liu, Mark M. Spiegel, Andrew Tai, Jun 20, 2017

The sharp appreciation of the U.S. dollar between mid-2014 and mid-2015 raised concerns in the U.S. and its major trading partners. Zheng Liu, Mark Spiegel, and Andrew Tai from the San Francisco Fed evaluate the impact of dollar appreciation on economic conditions in the United States and its three major Asian trading partners: South Korea, Japan, and China.

Physician-Induced Demand: Evidence from China’s Drug Price Zero-Markup Policy

Hanming Fang, Xiaoyan Lei, Julie Shi, Xuejie Yi, Aug 11, 2021

We exploit the staggered rollout of China’s drug price zero-markup policy (ZMP) to study physician-induced demand in healthcare. Our results show that the drug expenses in the treatment hospitals dropped by 63 log points (47 percent) compared with those of the control group; however, the expenses for non-drug services were 28 log points (32 percent) higher in the treatment group than in the control group. Our results provide robust evidence for physician-induced demand.